These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9059944)

  • 1. Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults.
    Chen XQ; Bülbül M; de Gast GC; van Loon AM; Nalin DR; van Hattum J
    J Hepatol; 1997 Feb; 26(2):260-4. PubMed ID: 9059944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults.
    Bruguera M; Bayas JM; Vilella A; Tural C; González A; Vidal J; Dal-Ré R; Salleras L
    Vaccine; 1996 Oct; 14(15):1407-11. PubMed ID: 8994314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
    Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A
    J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine?
    Zanetti A; Pregliasco F; Andreassi A; Pozzi A; Viganò P; Cargnel A; Briantais P; Vidor E
    J Hepatol; 1997 Jan; 26(1):25-30. PubMed ID: 9148018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.
    Ashur Y; Adler R; Rowe M; Shouval D
    Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years.
    Fan PC; Chang MH; Lee PI; Safary A; Lee CY
    Vaccine; 1998; 16(2-3):232-5. PubMed ID: 9607035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children.
    Newcomer W; Rivin B; Reid R; Moulton LH; Wolff M; Croll J; Johnson C; Brown L; Nalin D; Santosham M
    Pediatr Infect Dis J; 1994 Jul; 13(7):640-2. PubMed ID: 7970954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Sandman L; Davidson M; Krugman S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S50-2. PubMed ID: 7876649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.
    Goubau P; Van Gerven V; Safary A; Delem A; Knops J; D'Hondt E; André FE; Desmyter J
    Vaccine; 1992; 10 Suppl 1():S114-8. PubMed ID: 1335638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine.
    Maiwald H; Jilg W; Bock HL; Löscher T; Sonnenburg F
    Vaccine; 1997 Mar; 15(4):346-8. PubMed ID: 9141202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
    Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination.
    Totos G; Gizaris V; Papaevangelou G
    Vaccine; 1997 Aug; 15(11):1252-3. PubMed ID: 9286052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
    Guan R; Ng HS; Fock KM; Ho KY; Yap I; Kang JY; Chow WC; Chew CN; Ng C; Teo CJ
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):268-71. PubMed ID: 8629058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two immunization schedules with an inactivated hepatitis A vaccine (AvaximTM).
    Vidor E; Ratheau C; Briantais P; Vuillier D
    J Travel Med; 1998 Dec; 5(4):167-72. PubMed ID: 9876189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
    Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
    J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1997 Jun; 52(2):215-8. PubMed ID: 9179771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.
    Beck BR; Hatz CF; Loutan L; Steffen R
    J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years old.
    Arístegui J; Morales JL; Dal-Ré R; González A; Gallego MS; Garrote E
    Infection; 1995; 23(5):334-8. PubMed ID: 8557400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.